ORIGINAL RESEARCH article
Front. Public Health
Sec. Health Economics
Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1568351
Public Health Financing in Brazil (2019-2022): An Analysis of the FNS and Implications for Healthcare Management
Provisionally accepted- 1Federal University of Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil
- 2Sefako Makgatho Health Sciences University, Pretoria, South Africa
- 3The University of Manchester, Manchester, England, United Kingdom
- 4Laboratory Medicine Clinical Pharmacology, Strathclyde Institute of Pharmacy and Biomedical Sciences, Faculty of Science, University of Strathclyde, Glasgow, United Kingdom
- 5St George’s Hospital, London, United Kingdom
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The Unified Health System (SUS) in Brazil provides free, universal health services to all inhabitants of the country. This study aims to describe the allocation of public health resources in Brazil, both overall and across regions, based on National Health Fund (FNS) data from 2019 to 2022. The goal is to provide an understanding of the profile and distribution of resources sourced exclusively from the federal government during this period. Methods: A quantitative, descriptive study using data extracted from the FNS portal covering the period 2019-2022, along with publications and open data linked to Brazil's Ministry of Health, was undertaken. Data collection included the resources allocated to health within each of the financing blocks (operational and investment), according to FNS as well as the Transparency Portal of the Office of the Comptroller General for more information about the COVID-19 pandemic. Results: A total of USD 75.310 billion ( 406.283 billion BRL) was allocated to health services between 2019 and 2022, with 64.6% allocated to Specialized, Medium, and High Complexity Care and 30.2% to Primary Health Care (USD 21.096 billion). A lower percentage was dedicated to investment actions within the SUS, and there was heterogeneous distribution of resources across the country's regions, with the Southeast receiving the most resources (38.5%), while the Central-West region received only 7.7%. In addition, more than USD 111 billion (600 billion BRL) was allocated by the federal government to the COVID-19 pandemic response, not exclusively for health-related purposes. Conclusion: The distribution profile of resources transferred from the FNS reflected population sizes but it is less clear whether resources were allocated based on need. Overall, there was a scarcity of resources allocated to areas such as investment. However, the COVID-19 pandemic represented a considerable impact on government funds. Health and social needs must be assessed and considered going forward to improve the allocation of resources within a unified health system.
Keywords: Health financing, Resource Allocation, Public Health, Unified Health Systems, Challenges, Health management, Brazil
Received: 30 Jan 2025; Accepted: 12 May 2025.
Copyright: © 2025 Nunes Marinho, Campbell, da S. T. Amaral, Reis e Silva, Godman, Meyer and Godói. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Brian Godman, Laboratory Medicine Clinical Pharmacology, Strathclyde Institute of Pharmacy and Biomedical Sciences, Faculty of Science, University of Strathclyde, Glasgow, United Kingdom
Isabella Piassi Dias Godói, Federal University of Rio de Janeiro, Rio de Janeiro, 21941-901, Rio de Janeiro, Brazil
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.